Susquehanna International Group, LLP Evelo Biosciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$1.86 - $41.8 $4,278 - $96,140	2,300 Added 15.54%	17,100 $36,000
Q2 2022 Aug 15, 2022	BUY	$1.46 - $3.55 $2,774 - $6,745	1,900 Added 14.73%	14,800 $31,000
Q1 2022 May 16, 2022	SELL	$2.66 - $6.63 $270,256 - $673,608	-101,600 Reduced 88.73%	12,900 $44,000
Q4 2021 Feb 14, 2022	SELL	$6.07 - $12.0 $250,084 - $494,400	-41,200 Reduced 26.46%	114,500 $695,000
Q3 2021 Nov 15, 2021	BUY	$6.79 - $13.9 $765,912 - $1.57 Million	112,800 Added 262.94%	155,700 $1.1 Million
Q2 2021 Aug 11, 2021	BUY	$9.43 - $16.6 $404,547 - $712,140	42,900 New	42,900 $589,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.